The Di’ao Group, a Chengdu maker of TCM products, has gained approval in the European Union for its cardiovascular drug, Xin Xue Kang (地奥心血康). The product was approved for marketing by the Medicines Evaluation Board of the Netherlands, which gives it entry to all member states of the Union. Di’ao worked with the Netherlands Organization for Applied Scientific Research to identify the active ingredient of Xin Xue Kang. More details.... Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});